Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Donev

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|June 1, 1994
Islet amyloid polypeptide in Psammomys obesus: lack of correlation between insulin resistance and plasma IAPP levelsJ Duhault, M Boulanger, J Espinal, et al.
Bioscience Trends|January 20, 2016
Serum expression levels of miR-17, miR-21, and miR-92 as potential biomarkers for recurrence after adjuvant chemotherapy in colon cancer patientsNikolay V Conev, Ivan S Donev, Assia A Konsoulova-Kirova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2011
Transient PI3K inhibition induces apoptosis and overcomes HGF-mediated resistance to EGFR-TKIs in EGFR mutant lung cancerIvan S Donev, Wei Wang, Tadaaki Yamada, et al.
Future Cardiology|December 3, 2025
Plasma expression of lncRNA Wisper in patients with heart failure and patients with myocardial infarctionJordanka G Doneva, Veselin D Valkov, Ivan S Donev, et al.
The American Journal of Pathology|July 14, 2012
Dual inhibition of Met kinase and angiogenesis to overcome HGF-induced EGFR-TKI resistance in EGFR mutant lung cancerShinji Takeuchi, Wei Wang, Qi Li, et al.
Bioscience Trends|July 20, 2016
Serum levels of RIPK3 and troponin I as potential biomarkers for predicting impaired left ventricular function in patients with myocardial infarction with ST segment elevation and normal troponin I levels prior percutaneous coronary interventionJavor K Kashlov, Ivan S Donev, Jordanka G Doneva, et al.
Bioscience Trends|March 3, 2017
Role of the pretreatment <sup>18</sup>F-fluorodeoxyglucose positron emission tomography maximal standardized uptake value in predicting outcomes of colon liver metastases and that value's association with Beclin-1 expressionEleonora G Dimitrova, Borislav G Chaushev, Nikolay V Conev, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|March 25, 2019
RIPK3 expression as a potential predictive and prognostic marker in metastatic colon cancerNikolay V Conev, Eleonora G Dimitrova, Margarita K Bogdanova, et al.
Bioscience Trends|February 6, 2020
Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancerMila P Petrova, Mariyana I Eneva, Jeliazko I Arabadjiev, et al.
Clinical and Experimental Immunology|August 7, 2020
Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancerM P Petrova, I S Donev, M A Radanova, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|June 1, 1994
Islet amyloid polypeptide in Psammomys obesus: lack of correlation between insulin resistance and plasma IAPP levelsJ Duhault, M Boulanger, J Espinal, et al.
Bioscience Trends|January 20, 2016
Serum expression levels of miR-17, miR-21, and miR-92 as potential biomarkers for recurrence after adjuvant chemotherapy in colon cancer patientsNikolay V Conev, Ivan S Donev, Assia A Konsoulova-Kirova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2011
Transient PI3K inhibition induces apoptosis and overcomes HGF-mediated resistance to EGFR-TKIs in EGFR mutant lung cancerIvan S Donev, Wei Wang, Tadaaki Yamada, et al.
Future Cardiology|December 3, 2025
Plasma expression of lncRNA Wisper in patients with heart failure and patients with myocardial infarctionJordanka G Doneva, Veselin D Valkov, Ivan S Donev, et al.
The American Journal of Pathology|July 14, 2012
Dual inhibition of Met kinase and angiogenesis to overcome HGF-induced EGFR-TKI resistance in EGFR mutant lung cancerShinji Takeuchi, Wei Wang, Qi Li, et al.
Bioscience Trends|July 20, 2016
Serum levels of RIPK3 and troponin I as potential biomarkers for predicting impaired left ventricular function in patients with myocardial infarction with ST segment elevation and normal troponin I levels prior percutaneous coronary interventionJavor K Kashlov, Ivan S Donev, Jordanka G Doneva, et al.
Bioscience Trends|March 3, 2017
Role of the pretreatment <sup>18</sup>F-fluorodeoxyglucose positron emission tomography maximal standardized uptake value in predicting outcomes of colon liver metastases and that value's association with Beclin-1 expressionEleonora G Dimitrova, Borislav G Chaushev, Nikolay V Conev, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|March 25, 2019
RIPK3 expression as a potential predictive and prognostic marker in metastatic colon cancerNikolay V Conev, Eleonora G Dimitrova, Margarita K Bogdanova, et al.
Bioscience Trends|February 6, 2020
Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancerMila P Petrova, Mariyana I Eneva, Jeliazko I Arabadjiev, et al.
Clinical and Experimental Immunology|August 7, 2020
Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancerM P Petrova, I S Donev, M A Radanova, et al.
Pageof 4